WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003006024) MEDICINE CONTAINING PYRIMIDINE DERIVATIVE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/006024    International Application No.:    PCT/JP2002/007060
Publication Date: 23.01.2003 International Filing Date: 11.07.2002
Chapter 2 Demand Filed:    11.07.2002    
IPC:
A61K 31/519 (2006.01), C07D 487/14 (2006.01)
Applicants: BTG INTERNATIONAL LTD. [GB/GB]; 10 Fleet Place, Limeburner Lane, London EC4M 7SB (GB) (For All Designated States Except US).
ODA, Tomiichiro [JP/JP]; (JP) (For US Only).
URYU, Shigeko [JP/JP]; (JP) (For US Only).
TOKUHIRO, Shinya [JP/JP]; (JP) (For US Only)
Inventors: ODA, Tomiichiro; (JP).
URYU, Shigeko; (JP).
TOKUHIRO, Shinya; (JP)
Agent: OHNO, Akio; c/o SANKYO COMPANY, LIMITED, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140-8710 (JP)
Priority Data:
2001-213338 13.07.2001 JP
Title (EN) MEDICINE CONTAINING PYRIMIDINE DERIVATIVE
(FR) MEDICAMENT CONTENANT UN DERIVE DE PYRIMIDINE
Abstract: front page image
(EN)A medicine for central diseases which contains as the active ingredient either a compound represented by the general formula (I): (I) (wherein R1 represents hydrogen or C1−6 alkyl; R2 represents C1−6 alkyl, etc.; A represents carbon, etc.; D represents C1−6 alkylene, etc.; E represents carbon, etc.; and Arom represents aryl, etc.) or a pharmacologically acceptable salt of the compound.
(FR)L'invention concerne un médicament pour traiter les troubles du système nerveux central, contenant comme principe actif soit un composé représenté par la formule générale (I), dans laquelle R1 représente hydrogène ou C1-6 alkyle ; R2 représente C1-6 alkyle, etc. ; A représente carbone, etc. ; D représente C1-6 alkylène, etc. ; E représente carbone, etc. ; et Arom représente aryle, etc.) ou un sel pharmaceutiquement acceptable du composé.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)